News

News 27.10.2021 Shanghai, Rockville and Zurich - October 26, 2021 -SciNeuro Pharmaceuticals, a leader in the discovery and development of innovative therapeutics for the treatment of neurological diseases, and Mabylon AG, a leader in the discovery and characterization of human-derived antibodies against therapeutic targets, today announced the establishment of a multi-program collaboration...

News 26.10.2021 Schlieren (Zurich), Switzerland, 26 October 2021 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, today provided an update on its commercial activities. Direct sales of MagnetOs in the U.S. continued to accelerate in Q3 2021, with a year-to-date increase of 119% over the...

News 21.09.2021 Schlieren-Zurich, Switzerland, September 21, 2021. Proteomedix, the Swiss cancer diagnostics company has entered into a research and development partnership with New Horizon Health Limited (6606.SEHK). To support the joint program New Horizon Health has invested CHF 3.0 million in a convertible loan in Proteomedix. The partnership builds on complimentary platform...

Events, External events
Event date: 30.09.2021 3:00 – 4:00 PM (CEST) During this live event, we will discuss: - Different sample types - Proper sample collection for RNA extraction - Storage and shipping - Extraction methods - Quality criteria - Downstream services and their requirements As a takeaway we are happy to share a short list of Do’s and Dont’s. Of course, we will have...

News 16.09.2021 SCHLIEREN, ZURICH, September 16, 2021 — Anjarium Biosciences AG (“Anjarium”), a biotech company focused on creating and delivering a new class of non-viral gene therapies today announced the closing of a CHF55.5M ($61M) Series A financing. The round was co-led by Abingworth and Gimv, with significant participation from Omega Funds,...